KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Asset Writedowns and Impairment: 2022-2025

  • Guardant Health's Asset Writedowns and Impairment was N/A to $5.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $39.3 million, marking a year-over-year change of. This contributed to the annual value of $29.1 million for FY2023, which is 452.25% up from last year.
  • As of Q1 2025, Guardant Health's Asset Writedowns and Impairment stood at $5.0 million, which was down 78.79% from $23.6 million recorded in Q2 2023.
  • In the past 5 years, Guardant Health's Asset Writedowns and Impairment registered a high of $23.6 million during Q2 2023, and its lowest value of $5.0 million during Q1 2025.
  • Over the past 2 years, Guardant Health's median Asset Writedowns and Impairment value was $5.5 million (recorded in 2023), while the average stood at $11.4 million.